Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National Cancer Registration Service in England.

Autor: Goulden S; GSK, Brentford, UK., Heffernan K; GSK, Brentford, UK kiera.l.heffernan@gsk.com., Sen Nikitas F; GSK, Brentford, UK., Shukla U; GSK, Brentford, UK., Knott C; Health Data Insight CIC, Cambridge, UK.; National Disease Registration Service, Leeds, UK., Hunger M; ICON plc, Munich, Germany., Pahwa A; ICON plc, Bangalore, Karnataka, India., Schade R; ICON plc, Reading, UK.

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 Nov 06; Vol. 33 (11), pp. 1715-1723. Date of Electronic Publication: 2023 Nov 06.

PHP306 - Tissue/Site Agnostic Regulatory Approval of Oncology Drugs: Are Htas Ready For A New Era In Personalised Medicine?

Autor: Sammon, C, Mbanya, Z, Sen Nikitas, F

Publikováno v: In Value in Health October-November 2017 20(9):A705-A705

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.